Parmantier & Cie. GmbH

10.02.2025 - 11:17:11

PARMANTIER & CIE. Provides an Update on CLINUVEL Pharmaceuticals

EQS-Media / 10.02.2025 / 11:17 CET/CEST

Frankfurt am Main, February 25, 2025 – PARMANTIER & CIE. has updated its coverage of CLINUVEL Pharmaceuticals Ltd. (ASX: CUV - ADR Level1: CLVLY – Frankfurt/M Stock Exchange: UR9 - ISIN: AU000000CUV3). CLINUVEL has adjusted its corporate strategy at the turn of 2024 to focus on targeted expansion and accelerated development processes. By concentrating on key projects in clinical development, the company aims to significantly enhance both market penetration and enterprise value.
Despite a challenging macroeconomic environment, CLINUVEL has demonstrated positive operational developments following this realignment. The corporate strategy emphasizes the further development of SCENESSE® therapy for vitiligo, ACTH, and EPP, while deprioritizing less advanced projects. Furthermore, the introduction of the "PhotoCosmetics" product line represents a significant expansion of the business model. The market launch of CYACÊLLE Radiant is scheduled for 2025, with additional product lines to follow from 2026. This expansion into the non-pharmaceutical segment is expected to unlock further growth potential.

Our full research report on the latest developments of CLINUVEL Pharmaceuticals is available at:
Bloomberg/parmantiercie; Short code: {DS FMG <GO>}
PARMANTIER & Cie. Research https://www.parmantiercie.com/research

About PARMANTIER & CIE. GmbH:
PARMANTIER & CIE. specializes in advising and facilitating corporate financing solutions, including equity, debt, and hybrid financing, following the approach of a classic merchant bank. The firm invests in both publicly traded and private companies, combining the traditional values of honorable business conduct with innovative financing solutions tailored for a dynamic economic landscape. By actively engaging with its own capital, PARMANTIER & CIE. takes independent paths and provides customized financial solutions for both listed and private companies.

Contact:
PARMANTIER & Cie. GmbH
info@parmantiercie.com

End of Media Release

Issuer: Parmantier & Cie. GmbH
Key word(s): Finance

10.02.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com